January 2017 - Page 3 of 5

WednesdayJan 18, 2017 11:23 am

Mounting Support for Marijuana Banking Has Widespread Implications

Although 28 states have already legalized marijuana for medicinal or recreational use, the U.S. Drug Enforcement Administration (DEA) continues to label marijuana a Schedule 1 substance, along with heroin and LSD, making it illegal on a federal level. As a result, the banking industry has been slow to provide services to marijuana businesses, forcing many of these companies to operate on a cash-only basis. A "bankable" marijuana industry, however, would have widespread implications, including for companies like Singlepoint, Inc. (OTC: SING), Terra Tech Corp. (OTCQX: TRTC), OWC Pharmaceutical Research Corp. (OTCQB: OWCP), ChineseInvestors.com, Inc. (OTCQB: CIIX). Cash transaction businesses are…

TuesdayJan 17, 2017 1:41 pm

An Update on Axsome Therapeutics, Inc. (NASDAQ: AXSM)

Once New York-based Axsome Therapeutics, Inc. (NASDAQ: AXSM) was founded in 2012, its team set out to establish a fully-integrated biopharmaceutical business that would develop therapies to treat and manage central nervous system (CNS) disorders. Now in 2017, the Axsome team is setting off on another exciting leg on this journey. For years, Axsome has been laser-focused on improving the lives of patients living with pain and various CNS disorders. With an eye toward differentiated therapies, the company has concentrated on developing and commercializing both in-licensed drug candidates and internally-derived drug candidates in order to accomplish its goal of increasing…

TuesdayJan 17, 2017 12:55 pm

National Waste Management Holdings, Inc. (NWMH) Turns Trash into Treasure, Records Strong Revenue Growth

National Waste Management Holdings, Inc. (OTC: NWMH) has turned the old aphorism ‘garbage in – garbage out’ on its head. It’s now ‘garbage in, revenues up’. In its last 10-Q filing, for the third quarter ended September 30, 2016, the company reported quarterly revenues of $1.8 million, which represented a 269 percent increase over 2015 same period revenues. This stellar performance in the third quarter boosted revenues in the nine-month period ended September 30, 2016, to $4.9 million, up by 262 percent over same period revenues for 2015. Not all garbage, it seems, is waste. National Waste operates a licensed…

TuesdayJan 17, 2017 10:27 am

Lomiko Metals, Inc. (LMRMD, LMRMF) Offers One of the Brightest Potentials in Mining and Materials

Lomiko Metals (OTCQB: LMRMD) (OTC: LMRMF) has positioned itself on top of an extremely positive supply-demand curve, with a unique opportunity for low-cost production of a key mineral that underpins much of the growing green economy. Lomiko’s core focus is on the exploration and development of minerals such as lithium and graphite, the latter of which is used for energy storage in products such as lithium-ion batteries, especially those used for electric vehicles (EV), and for which there is no cheaper alternative. The demand for EVs is expected to see rapid growth for at least the next 20 years, and…

FridayJan 13, 2017 2:27 pm

DelMar Pharmaceuticals (NASDAQ: DMPI) Given a ‘Buy’ Rating and $16 Price Target by Aegis Capital

Biotechnology company DelMar Pharmaceuticals (NASDAQ: DMPI) has been given a ‘Buy’ rating by Aegis Capital Corp. and a $16 price target (http://dtn.fm/jZlI7). The company was trading at $3.29 on January 11, 2016. To reach that price target, Aegis, in its initiation of coverage, said that it applied a 15x multiple after estimating the company's 2022 EPS at $3.93, then discounting it by 30%. DelMar Pharmaceuticals has been developing its lead product candidate, VAL-083, as a chemotherapy for cancer. Specifically, VAL-083 would be used in the treatment of glioblastoma multiforme (GBM), the most common form of a fatal and aggressive brain…

FridayJan 13, 2017 1:41 pm

MassRoots, Inc. (MSRT) Achieves Incredible Growth in 2016

MassRoots, Inc. (OTCQB: MSRT), a company offering cannabis enthusiasts the chance to share their cannabis content while staying connected with news and the latest legislation regarding the drug through a specialized social media platform and iOS application, has shown significant growth in the rapidly developing cannabis industry. According to a SeeThruEquity update (http://dtn.fm/Y0Har), MassRoots achieved phenomenal growth in 2016, with revenue reaching $794,621 during the first three quarters of 2016, compared to just $63,982 during the same period of the previous year. This performance was attributed to the company’s ability to monetize its users, which increased by 1,140% as compared…

ThursdayJan 12, 2017 2:53 pm

ChineseInvestors.com, Inc. (CIIX) Offers Unique Path to Global Chinese Investor and Consumer Market

Founded in 1999, and with offices in the U.S. and China, ChineseInvestors.com, Inc. (OTCQB: CIIX) acts as a growing Chinese-language investment information and services conduit to the global Chinese investor community. Primarily through its websites, the company provides different levels of investment information, both free and via subscription, including information on the U.S. market and foreign currencies, covering sectors as well as companies, real-time market news and analysis, quotes, charts, and research tools. The company is led by chairman and CEO Warren Wang, COO Brett Roper, CFO Paul Dickman, and Director James Toreson. The company’s stated mission is to ‘educate…

ThursdayJan 12, 2017 10:27 am

GainClients, Inc. (GCLT) has Disruptive Marketing Solutions for Real Estate Professionals

GainClients, Inc. (OTC: GCLT) is disrupting the real estate marketing and advertising industry. Its GCard mobile technology platform ‘allows the loan originator, the real estate sales person, or the “title guy” to succeed in this marketplace’. In an interview with RedChip (http://dtn.fm/ez6tY), CEO of GainClients, Ray Desmond, discussed the concepts behind his company’s business model. GainClients, it appears, is attempting to monetize the store of data and knowledge amassed by CEO Ray Desmond over his 36 years in the real estate industry. “We’ve created our daily opportunities product that allows us to catch that person that’s selling their house that…

WednesdayJan 11, 2017 5:24 pm

Cytosorbents Corp. (NASDAQ: CTSO) Expected to Announce Doubling in Sales for 2016

Cytosorbents Corp. (NASDAQ: CTSO), a critical care-focused immunotherapy company engaged in the research, development, and commercialization of medical devices, most prominently its platform blood purification technology that incorporates a proprietary adsorbent polymer technology, recently pre-announced unaudited results (http://dtn.fm/bKG3F) for fiscal 2016 ahead of its Form 10-K filing. Cytosorbents expects to announce between $8.1 and $8.3 million in Cytosorb sales for the whole of 2016. This equates to more than double the total from the previous year. Cytosorb is the company’s flagship product, a blood filter that helps treat deadly inflammation in critically-ill and cardiac surgery patients across the globe. In…

WednesdayJan 11, 2017 3:47 pm

Aegis Restates ‘Buy’ Rating on Shares of Rosetta Genomics Ltd. (NASDAQ: ROSG)

Rosetta Genomics, Ltd. (NASDAQ: ROSG), a company in the business of developing and commercializing MicroRNA-based and other molecular diagnostics, recently had its 'Buy' rating restated by Aegis Capital Corp. (http://dtn.fm/l0Yk0) with a price target of $3.50 per share. This was based on Aegis’ 2017 revenue estimate of $17.7 million with a multiple of 4X. The company update was released after Rosetta Genomics Ltd. announced a new collaboration to determine biomarkers that can predict response to Opdivo, a PD-1 immunotherapy. In addition to the above, Aegis Capital Corp. announced expectations for Rosetta Genomics’ cash deliverables to be over $9 million by…

Site Search

Company Search

Month: January 2017